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’ INTRODUCTION
Amyloidosis relates to a group of diseases with amyloid ﬁbrils
deposition and protein aggregation. Among the well-known
amyloid diseases are Alzheimer’s, Parkinson’s, Huntington’s,
and Prion disorders.1,2 Alzheimer’s is characterized by extracel-
lular deposition of aggregated amyloid-beta (Aβ) as senile
plaques and neuroﬁbrillary tangles.3,4 However, in diseases such
as Prions and Parkinson’s intercellular aggregations have been
observed.5 Amyloid formation has been seen in both folded
proteins and natively disordered ones. In folded proteins, a
partial denaturation can lead to misfolding and amyloid forma-
tion, whereas in a natively disordered one, a folding intermediate
can be formed that could lead to formation of amyloid ﬁbrils.6,7 A
protein that undergoes amyloidosis displays a number of phy-
siochemical characteristics that discern the amyloid forma-
tion from amorphous aggregation; these include an increase in
β-sheet content, binding to amyloid speciﬁc dyes (Thioﬂavin T and
Congo Red), birefringence, speciﬁc β-cross ﬁbril formation, and
toxicity of both intermediates (oligomers) and the ﬁbril.4,8,9
Understanding the self-assembly of proteins into ﬁbrils has been
crucial in ﬁnding inhibitors for amyloid formation.10 Another usage
of amyloid ﬁbrils have been in nanotechnology where ﬁbrillar
proteins, because of their unique biophysical characteristics, have
been utilized to produce novel biomaterials such as nanowires and
nanoscalfolds.11,12 Therefore, there is a surge in ﬁnding novel ways
to produce protein self-assembled biomaterials.
Transglutaminase 2 belongs to a widespread enzyme family of
transglutaminases that catalyze Ca2+-dependent acyl-transfer
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ABSTRACT: Tissue transglutaminase (tTG or TG2) is a
member of the transglutaminase family that catalyzes calcium
dependent formation of isopeptide bonds. It has been shown
that the expression of TG2 is elevated in neurodegenerative
diseases such as Parkinson’s, Huntington’s, and Alzheimer’s.
We have investigated the self-assembly of TG2 in vitro. First,
using software, hot spots, which are prone for aggregation, were
identiﬁed in domain 2 of the enzyme. Next we expressed and
puriﬁed recombinant TG2 and its truncated version that
contains only the catalytic domain, and examined their amyloi-
dogenic behavior in various conditions including diﬀerent tem-
peratures and pHs, in the presence of metal ions and Guanosine
triphosphate (GTP).
To analyze various stages leading to TG2 ﬁbrillation, we employed various techniques including Thioﬂavin T (ThT) binding assay,
Congo-Red, birefringence, Circular Dichroism (CD), 8-anilino-1-naphthalene sulfonic acid (ANS) binding, Transmission Electron
Microscopy (TEM) and Atomic Force Microscopy (AFM). Our results indicated that using low concentrations of Ca2+, TG2 self-
assembled into amyloid-like ﬁbrils; this self-assembly occurred at the physiological temperature (37 C) and at a higher temperature
(57 C). The truncated version of TG2 (domain 2) also forms amyloid-like ﬁbrils only in the presence of Ca2+. Because amyloid
formation has occurredwith domain 2 alonewhere no enzymatic activity was shown, self-cross-linking by the enzymewas ruled out as a
mechanism of amyloid induction. The self-assembly of TG2 was not signiﬁcant with magnesium and zinc ions, indicating speciﬁcity of
the self-assembly for calcium ions. The calcium role in self-assembly of TG2 into amyloid may be extended to other proteins with
similar biophysical properties to produce novel biomaterials.
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reactions, and the enzyme produces intra- and intermolecular
isopeptide bonds in proteins.3,13 The products of enzyme activity are
stable, rigid, and insoluble protein complexes that show resistance
to 2% sodium dodecyl sulfate (SDS) and 8 M urea or enzymatic
degradations. These complexes are similar to the protein aggregates
that are present in neurodegenerative diseases.14 Moreover, elevated
expressions and activity of TG2 (tissue transglutaminase) have been
found inmost neurodegenerative diseases;3Aβ,R-synuclein, tau, and
huntingtin are among TG2 substrates.15
Recent studies have shown that isopeptidase activity increases
along with increased TG2 activity in Alzheimer's disease.3
Indeed, colocalization of TG2 occurs with aggregated Aβ in
senile plaques and tau in neuroﬁbrillary tangles.14 TG2 employs
stringent speciﬁcity in distinguishing an acyl donor, and poor
speciﬁcity for the acyl-acceptor amine group.15 The substrates for
TG2 have been found, as a growing list, in a number of biological
processes; they encompass cytoskeleton network organization
proteins such as actin, myosin, and ﬁlamin 1,15,16 factors involved
in protein folding including heat shock proteins,16 proteins in
transport processes like clathrin heavy chain, and importin β1
subunit,16 and matrix-associated proteins, exempliﬁed by col-
lagen, ﬁbronectin, and laminin.15,16
TG2 has four structural domains (Figure 1A), with an
N-terminal β-sandwich, catalytic core, and two β-barrels in its
C-terminal. Several binding sites have been identiﬁed for TG2.
Binding site for ﬁbronectin and integrin in domain 1, interaction
site for phospholipase Cδ1 in domain 4, and Ca
2+ and guanosine
triphosphate (GTP)-binding sites in domains 2 and 3,
respectively.13 TG2 catalyzes several biological reactions in the
cell at diﬀerent cellular localization; in addition to its isopeptidase
activity, TG2 can modulate proteins via incorporating amine and
also carrying out protein deamidation. TG2 is also known to
possess GTP hydrolyzing activity by which it is involved in cell
signaling.13,17 Recently, TG2 has been found to show kinase
activity and disulﬁde isomerase activity as well.18,19 TG2 iso-
peptidase catalytic activity requires millimolar concentrations of
Ca2+ and is inhibited by guanine nucleotides. Therefore, the
intracellular TG2 does not perform enzymatic activity, but rather
it functions as a G-protein in the phospholipase C mediated
signal transduction.20 However, in the extracellular matrix, it
performs its Ca2+-dependent activity and binds tightly to both
ﬁbronectin in the extracellular matrix and integrin as a co-
receptor on the cell surface; as a result, TG2 could aﬀect cell
adhesion, signaling, motility, and diﬀerentiation without depen-
dence on its catalytic activity.20,21
In the present study, we have examined the amyloidogenic
properties of TG2. Initially, we became more interested in
studying TG2 amyloid formation because online aggregation
software predicted a number of regions as “hot spots” for ag-
gregation. Additionally, as mentioned previously, TG2 has been
found to colocalize with aggregated Aβ in senile plaques and tau
in neuroﬁbrillary tangles.
In order to study TG2 in vitro, bacterially expressed TG2- and
its truncated version (139480 a.a.) were puriﬁed; the truncated
version encompassed the core of the enzyme, the catalytic
domain. Furthermore, various conditions were applied to study
the behavior of TG2. The results indicate that TG2 self-
assembled to form amyloid ﬁbrils in the presence of a physiolo-
gical concentration of Ca2+ at 37 C and at an elevated temper-
ature (57 C). The aggregations that are formed have a number
of physiochemical characteristics of amyloid and are toxic to human
cells. The truncated version also forms amyloid in the presence of
Ca2+; this result eliminates self-cross-linking by the enzyme as a
cause of amyloid formation since the truncated version lacks the
isopeptidase activity and still forms amyloid ﬁbrils in the presence of
Ca2+. Using metal ions to self-assemble non-amyloidogenoic
biomolecules into amyloids can be exploited to produce novel
biomaterials for various applications in nanotechnology.
’RESULTS
TG2 Contains Aggregation-Prone Regions. Although many
proteins can, in some in vitro conditions, form aggregates, there
are some local regions in the polypeptide sequence that contain
“hot spots” for aggregation.22 Indeed, with a great accuracy, using
algorithms that consider physiochemical properties of proteins, one
can predict these sensitive areas.2225 Therefore, the first approach
was to examine the TG2 sequence for “hot spot” regions, using
various software such as TANGO, PASTA, andWaltz. As shown in
Figure 1B, using TANGO, TG2 appears to possess a few aggrega-
tion-prone regions belonging to domain 2, the domain responsible
for catalysis. Other software such as Amylpered and Waltz also
predicted “hot spots” that are mostly localized to the catalytic
domain of the polypeptide (data not shown).
Ca2+ Self-Assembles TG2, Showing Amyloid-Specific Dye
Binding.To study TG2 in vitro, the TG2 cDNA was cloned into
the bacterial expression vector and the recombinant protein was
purified using affinity chromatography (Supporting Information
Figure S1) and described in detail in theMaterials andMethods
section. The activity of purified TG2 was examined and it
showed activity in the presence of 10 mM Ca2+ as described
previously.26,27
In order to study the aggregation properties of TG2, various in
vitro conditions were examined including acidic and alkaline
Figure 1. Schematic structure of TG2. (A) 3D structure of TG2
(1FAU). N- and C-terminals are shown by N and C. TG2 domains
include an N-terminal β-sandwich domain, a catalytic core, and two
C-terminal barrels. (B) Predicting amylogenic regions of tissue trans-
glutaminase usingTANGO software. Most of the amylogenic regions are
located in the catalytic domain.
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environments, changes in temperature, GTP addition, and
diﬀerent metal ion concentrations (Figure 2A,B). The last two
factors, namely, GTP and metals, were examined in addition to
the generic factors such as temperature and pH change in lieu of
TG2 interactionwith both nucleotides andCa2+. To our surprise,
only in the presence of Ca2+ was aggregation seen with TG2 in
pH ranging from 7.0 to 8; indeed, the aggregation was visible at
an elevated temperature (57 C) by the naked eye after about
four hours. As shown in Supporting Information Figure S2, the
aggregation measured at 350 nm as turbidity28 was increasing as
the time of incubation increased, in the presence of Ca2+. The
aggregation was not detected in the presence of Na+ or at the
high temperature alone (Figure 2A,B).Moreover, in extreme pH,
very acidic or very alkaline, no aggregation was detected, and in
the presence of GTP (100 μM), no aggregation was detected
with TG2 either (data not shown).
To better study the nature of TG2 aggregation in the presence
of calcium ions, Thioﬂavin T (ThT) binding assay was con-
ducted. Indeed, one of the main methods to detect amyloid
formation is ThT binding assay.29 TG2 was incubated at
physiological temperature (37 C) and elevated temperature
57 C in the presence or the absence of metal ions, namely, Ca2+
and Na+. As shown in Figure 2A,B, TG2 showed ThT binding
only in the presence of calcium regardless of temperature. TG2 in
the presence of Na+ did not show any ThT binding. This result
was quite interesting to us, and therefore, we decided to examine
various concentrations of the metals in amyloid formation of
TG2 in vitro. As shown in Supporting Information Figure S3A,
various physiological concentrations of Ca2+ did show ThT
binding, but the maximum binding was at 10 mM of Ca2+.
TG2Displays β-Sheet Enrichment and Exposure of Hydro-
phobic Region in the Presence of Ca2+. In order to study the
conformational changes that take place in the presence of
Ca2+ ions, circular dichroism (CD) spectroscopy was performed.
The enrichment of β-sheet took place only whenCa2+ was present;
at high heat alone or in the presence of Na+, the conversion to
β-sheet secondary structure did not occur (Figure 3A,B). As
shown in Figure 3C, only in the presence of Ca2+ there was a
great increase in absorbance near 218 nm, corresponding to the
β-sheet secondary structure. The enrichment of β-sheet struc-
ture is one of the hallmarks of amyloid formation that is seen with
many amyloid forming proteins.30,31
To further investigate the mechanism of TG2 amyloid forma-
tion, 8-anilino-1-naphthalene sulfonic acid (ANS) binding was
measured during TG2 amyloid formation in the presence or
absence of metal ions. In the presence of various concentrations
of Na+, ANS binding did not change much (data not shown).
However, in the presence of Ca2+, ANS binding increased,
indicating that structural changes had occurred in the presence
of the divalent ion (Figure 4A). Generally, ANS binding increases
as more of the hydrophobic region in protein is exposed to the
solvent. Indeed, the increased ANS binding is seen when amyloid
formation takes place due to exposure of proteins as it undergoes
protein ﬁbrillation.30
TG2 Aggregates Display Amyloid-Like Morphology and
Display Birefringence. In order to visualize the morphology of
TG2 aggregates, TG2 samples in the presence of Ca2+ were
examined using transmission electron microscopy (TEM). As
shown in Figure 4B and Supporting Information Figure S3B,
TEM negative stains indicated that the TG2 aggregates in the
presence of Ca2+ displayed amyloid-like fibrils. However, as a
number of samples were examined, we did not find an abundance
of fibrils but rather aggregates of proteins that look more like
amorphous aggregations (data not shown). To obtain better
results, we performed atomic force microscopy (AFM) to detect
fibrils. As shown in Figure 4C, the AFM analysis confirmed the
presence of amyloid-like fibrils in TG2 samples that were
incubated in the presence of calcium ions. The height distribu-
tion of a good fraction of fibrils turned out to be 9 nm
(Figure 4D).
One of the ultimate tests for conﬁrming amyloid ﬁbrils is
birefringence.32 The amyloid ﬁbril, stained with Congo Red,
when viewed under cross-polarized light generates greenblue
light. As shown in Figure 5, TG2 ﬁbrils were examined for
birefringence. Under cross-polarized light, TG2 ﬁbrils in the
presence of Ca2+ at both 37 C and higher temperature (57 C)
displayed the bluegreen birefringence. However, TG2 that was
incubated in the presence of Na+ did not demonstrate any
birefringence (Figure 5C).
Domain2AloneCanSelf-Assemble in thePresenceofCa2+;
Aggregates of TG2 and Its Truncated Version are Toxic
to Human Cells. As our data have indicated, TG2 is able to form
amyloid in the presence of Ca2+. However, TG2 has several
domains (Figure 1A) that could be involved in amyloid forma-
tion. The catalytic domain of the enzyme is located in domain 2
(D2) where all the known calcium binding sites are also located.
As described in Materials and Method, D2 region, spanning
residues 139 to 480, was cloned and expressed in bacteria.
Although the domain is much smaller than TG2, it formed
inclusion bodies much greater than TG2 itself. Nevertheless,
after refolding and purification of the truncated domain
(Supporting Information Figure S4), D2 was used in the
Figure 2. TG2 Thioﬂavin T binding assay in the presence of metal ions.
The puriﬁed TG2 (0.2 mg/μL) was incubated at pH 8 (glycine 50 mM)
in the presence of metal ions for several days at two diﬀerent tempera-
tures. At each time, 30 μL aliquots of samples were taken to measure for
ThT binding assay. The standard deviation represents the average of
three independent repeats. (A) TG2 samples were incubated at 57 C.
(B) TG2 samples were incubated at 37 C.
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aggregation assay in the presence of Ca2+. As shown in
Figure 6A, D2 alone was able to form amyloid in the presence
of Ca2+ alone. To further confirm the amyloid formation,
birefringence assay was performed, and it also proved positive
for the presence of amyloid (Figure 6A). Since D2, which lacks
any enzymatic activity on its own, was able to form amyloids,
the self-cross-linking activity of enzyme is ruled out as a primary
cause of amyloid formation. As shown in Figure 6C, the TEM
negative stain of D2 in the presence of Ca2+, showed amyloid-
like fibrils.
One of the important characteristics of amyloids relates to
their toxicity. To examine the amyloid formed by TG2 and its
truncated version (D2), RBC hemolysis was performed as
previously reported.33 As shown in Figure 7, the amyloids
formed in the presence of Ca2+ from both TG2 and D2 are
cytotoxic to human RBC. The cytotoxicity was at a maximum
from the protein samples that were exposed to 10 mM Ca2+
during aggregation assay.
’DISCUSSION
Tissue transglutaminase, known as “natural glue”, has been
shown to be involved in number of important biological
reactions.15 The enzyme through its cross-linking activity shapes
ECM and regulates apoptosis, for example, cross-linking caspase
3.34 It also regulates several proteins that are involved in
apoptosis through its GTPase activity .When calcium concentra-
tion is elevated, TG2 undergoes a large conformational change to
become an isopeptidase otherwise it acts as a GTPase.35 In a few
neurodegenerative diseases, the expression and the activity of the
enzyme is upregulated.3,14,15 More interestingly, TG2 has been
found to be colocalized with amyloidogenic proteins including
tau and Aβ.3 In addition, it has been somewhat controversial
whether the proteins that are cross-linked by TG2 are of amyloid
type or simply amorphous aggregations.36
In this study, we have examined the self-assembly of TG2 and
its catalytical domain into amyloids. Our results clearly indicate
that TG2 at physiological concentrations of Ca2+ can form
Figure 3. Near-UV CD spectra of TG2 incubated at 57 C. Aggregation assay was done as described in the legend of Figure 2. Aliquots (0.2 mg/mL) were
taken forCD analysis. (A) 1:NativeTG2. 2: TG2 after 24 h. 3: TG2 after 288 h. (B) 1:NativeTG2. 2: TG2 in the presence of 10mMNa+ after 24 h. 3: TG2 in
the presence of 10mMNa+ after 288h. (C) 1:NativeTG2. 2:TG2 in the presence of 10mMCa2+ after 24 h. 3: TG2 in the presence of 10mMCa2+ after 288 h.
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protein ﬁbrils. The catalytical domain (D2) on its own was also
shown to form amyloid at physiological concentration using
Ca2+. Since domain 2 of TG2 did not show enzymatic activity,
the cross-linking of the enzyme was ruled out as the mechanism
of the amyloid formation.
The signiﬁcance of our work relates to the initiation of TG2
amyloid formation by calcium ions. There have been a handful of
amyloidogenic proteins where the rate of their amyloid forma-
tion is aﬀected upon metal ion treatment: to name a few, R-
synuclein in the presence of Hg+,31 Aβ when exposed to Ca2+
and Cu2+,37,38 and islet amyloid poly peptide (IAPP) in the
presence of Zn2+.39 However, TG2 is not considered an amyloi-
dogenic protein, and Ca2+ actually initiates TG2 amyloid forma-
tion under our conditions. In other words, the Ca2+ interaction
with TG2 makes up a unique case in which metal ions can
convert a non-amylogenic protein into amyloid. Calcium ions
have been used to promote the self-assembly of R-lactalbumin to
nanotubes when the protein was hydrolyzed42 but not when the
protein was in its native form as in our study; other divalent metal
ions could have also formed the self-assembled R-lactalbumin,40
whereas in our study, only Ca2+ among the divalent ions examined
could produce any signiﬁcant amyloid ﬁbrils (Figure 8).
How could Ca2+ bring about TG2 amyloid formation? As
aforementioned, TG2 is a calcium binding protein that under-
goes a conformational change upon binding to calcium.35 The
metal interaction can break the interaction between domain 2
(the catalytic domain) and domains 3 and 4, leading to move-
ment of protein domains.15 The exact calcium binding sites have
not been identiﬁed for TG2, but up to 6 sites have been predicted
to be the calcium binding sites. In recent studies, ﬁve noncano-
nical Ca2+ for TG2 have been characterized;41 indeed, because
TG2 has several negatively charged amino acids which display
high surface potential, three might be more Ca2+ binding sites
than have been characterized.42 Interestingly, an active site
mutant (C277S) of TG2, although shown to lack enzyme
activity, was found to bind 6 Ca2+.41 In other words, calcium
binding is not dependent on TG2 enzymatic activity.41,43 In
fact, all of the calcium binding sites are located in domain 2, the
catalytic domain.
The mechanism that we propose for the amyloid formation of
TG2 relates to the roles of these extra calcium sites that we like to
call “cryptic” sites. In the normal situation when TG2 is
performing its catalytic reaction, the cryptic sites are not calcium
bound as much. However, in situations where the enzyme is
exposed to a high concentration of the ions, the cryptic sites are
calcium bound, and as a result, the protein undergoes a huge
conformational change in the direction of β-sheet enrichment, as
evidenced by the CD and ANS analyses. Once the protein is
forced to unfold, misfolding could take place and amyloid
formation would be the next step.
Figure 4. TG2 ANS binding assay and Morphology of TG2 aggregates using TEM and AFM. TG2 ﬁbrillation was done as explained in the legend of
Figure 2. At each time point, aliquots were removed for the reaction for ANS binding. For TEM andAFM, the samples from the last time point were used.
(A) ANS binding assay of TG2 in the presence of metal ions. (() TG2 Native, (9) TG2 in the presence of 10 mM Na+ after 288 h, (2) TG2 in the
presence of 10 mM Ca2+ after 288 h. (B) TEM of TG2 aggregates generated at 57 C in the presence of calcium ions. The ﬁbrillation was done as
explained in the legend of Figure 2. The samples were taken at the end of ﬁbrillation reaction (288 h). (C) AFM phase image of TG2 aggregates at 57 C
in the presence of calcium ions. The ﬁbrillation reaction was performed as explained in the legend of Figure 4B. (D)Height distribution of ﬁbrils detected
by AFM.
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Could TG2 self-cross-linking initiate amyloid formation?
Since TG2 was shown to cross-link itself,44 there is a possibility
that self-cross-linking by the enzyme could occur, leading to
amyloid formation. However, as shown in Supporting Infor-
mation Figure S5, the activity was sharply reduced as the
incubation time increased, whereas the amyloid formation
increased (Figure 2A). More importantly, domain 2 which
should not have any enzyme activity (data not shown) due to
the omission of several substrate recognizing domains, still
gave rise to amyloid formation in the presence of Ca2+
(Figure 6). Therefore, the self-cross-linking of TG2 under
our conditions is not the primary reason for the amyloid
formation.
Another important question is whether the self-assembly
seen by calcium could be seen with other metal ions? To answer
this question, we examined two other divalent metal ions,
namely, zinc and magnesium. None of the ions examined
showed any signiﬁcant self-assembly with TG2, indicating the
speciﬁcity of calcium ions in the self-assembly (Figure 8). There
is also one more line of evidence in the literature that supports
our ﬁndings. Factor XIII which is actually a member of the
transglutaminase family has been predicted to have an amyloi-
dogenic region, and the protein was shown to form amyloid at
37 C.45
What would be the consequences of TG2 amyloid induced
formation in extra cellular matrix (ECM)? There exist many
calcium binding proteins in ECM such as cadherin, BM-40, and
ﬁbrillin that contain several epidermal growth factor (EGF)
modules.42,4547 For those proteins, Ca2+ has been proposed
to help in structure stabilization, active site optimization, and
formation of supramolecular assembly.47 Since the concentration
of Ca2+ in ECM at some sites reaches up to 26 mM,48 there is a
possibility that the calcium binding proteins of ECMundergo the
same amyloid formation as TG2 does under our assay conditions.
Indeed, in this sense the calcium binding proteins can behave
more like functional amyloids that have been seen with a growing
number of proteins and peptides.48 Therefore, it could be
Figure 5. Detection of TG2 amyloid using Congo Red birefringence
assay. Green birefringence was done as described inMaterials andMethods.
TG2 aggregation was set up as described in the legend of Figure 2.
(A) TG2 aggregate in the presence of Ca2+ after 288 h incubation at
57 C. (B) TG2 aggregate in the presence of Ca2+ after 288 h incubation at
37 C. (C) TG2 in the presence of Na+ after 288 h incubation at 57 C.
(D) Lysozyme ﬁbrils as positive control. Magniﬁcation 250.
Figure 6. ThT binding assay, birefringence assay, and TEM for domain 2 (D2) at 57 C. The aggregation assay was set up as described in the legend of
Figure 2 except that Domain 2 (D2) was used as the source of the protein. (A) ThT binding assay for D2 aggregate. The reaction was performed as
described. (B) Congo Red birefringence assay for D2 sample that was incubated in the presence of Ca2+ after 288 h. (C) Electron micrographs obtained
of in the presence of Ca2+ after 288 h incubation at 57 C.
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interesting to check other calcium binding proteins that reside in
ECM for the amyloid formation.
Another important issue is whether the TG2 amyloid forma-
tion can be seen in vivo. Indeed, the above question should be
investigated in mammalian organisms or tissue cultures expres-
sing TG2. As we were preparing the present manuscript for
submission, a very recent paper reported that the maize trans-
glutaminase can form amyloid-like aggregates in plant cells.49
Therefore, there is a good possibility that TG2 can form amyloids
in a mammalian system.
At the moment, we are examining the eﬀects of other divalent
metal ions in the amyloid formation of TG2. In addition, we are
planning to better localize the aggregation sites by changing a few
calcium binding sites in domain 2 by site-directed mutagenesis,
and also investigate the TG2 amyloid formation in themammalian
expression system.
’CONCLUSION
In our present studies, we showed that TG2 self-assembled in
the presence of a physiological concentration of calcium ions.
Using a number of approaches, we show that the self-assembled
TG2, induced by Ca2+, was indeed amyloid. Domain 2 of TG2
alone was shown to form amyloid as well, indicating that the TG2
amyloid formation was not due to self-cross-linking of TG2 by its
enzymatic activity. The self-assembly, induced by Ca2+, occurred
at both low and relatively high temperature, revealing the sole
role of calcium in the amyloid formation. Our results can be
important on several fronts; this is the ﬁrst time that a non-
amyloidogenic TG2 has been shown to form amyloid in the
presence of metal ions. Furthermore, our ﬁnding that calcium
ions speciﬁcally can induce self-assembly of TG2 into ﬁbrils may
Figure 7. Cytotoxicity assay for TG2 and D2 aggregates. One milliliter of isolated RBC was incubated 40 min at 37 C in the presence of (A) various
concentrations of metal ions alone or TG2 samples generated in the presence of 10 mM Ca+2 or Na+ after 288 h. (B) ﬁrst column (from left to right),
TG2 incubated at 37 C in the presence of Ca2+ after 288 h; second column, D2 incubated at 57 C in the presence of Ca2+ after
288 h; third column, 0.1 mM Ca2+; fourth column, 0.1 mM Na+ and after that the absorbance of supernatant were measured at 540 nm.
Figure 8. ThT binding assay for TG2 in the presence of diﬀerent metal
ions. The puriﬁed TG2 (0.2 mg/μL) was incubated at pH 8 (Glycine
50 mM) in the presence of diﬀerent divalent ions for several days. All
samples were incubated at 57 C. Aliquots were taken at various time
points of ThT binding assay as described in the Materials and Methods.
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suggest the existence of other proteins with similar chemicophy-
sical properties as TG2 that can be self-assembled into novel
biomaterials using the metal ions.
’MATERIALS AND METHODS
Prediction of Amylogenic Regions for Aggregation. To
predict the propensity of TG2 for aggregation, we used online software
such as Tango, Waltz, and Amylpered.50 These programs are specialized
for the detection of regions within a protein which are prone to protein
aggregation.
Cloning, Expression, and Refolding Purification of TG2
and Its Domain2 (D2). The following primers were used to subclone
the TG2 cDNA (a gift from Prof. Daniel Aeschlimann) into pET28a
bacterial expression vector: 50AACCTCGAGTTAGGCGGGGCCAA-
TGATGACATTCC 30 (EcoR I cloning site, underlined) and 50CC-
GGAATTCATGGCCGAGGAGCTGGTCTTAGAGAGG30 (Xho I
cloning site, underlined). For cloning Domain2, spanning nucleotides
4201440, corresponding to 139480 amino acids of TG2, the
following primers were used: 50ATTCCATATGAACGCCTGGTG-
CCCAG30 (Nde I cloning site, underlined) and 50ACGCGTCGACT-
TAGCCCACACGGATC30 (SalI cloning site, underlined). The PCR
reactions were performed as recommended by Sambrook and Russell
using LA-Taq (Takara, Japan).The amplified products were purified and
digested using the restriction enzymes and subsequently ligated and
transformed into bacteria. The correct clones were chosen for DNA
sequencing (Macrogen, Korea). The best condition for expressionwas at
1 mM Isopropyl β-D-1-thiogalactopyranoside IPTG (Fermentase,
Lithuania), 4 mM lactose (Merck, Germany), and the cells were
incubated at 22 C for 14 h as previously reported.51,52 1020% of
TG2 expressed protein was found in the soluble fraction, whereas
domain 2 (D2) was found entirely in inclusion bodies. The proteins
that were found in inclusion bodies were refolded using urea gradient as
described elsewhere.52 Purifications of the recombinant proteins were
done using Ni-sepharose (Sigma, Germany). The purified proteins were
dialyzed overnight in 50 mM glycine buffer, pH 8, and 1 mM 2-mer-
captoethanol (Merck, Germany). The protein solution was concen-
trated using stirred ultrafiltration cell (Amicon, USA), and protein
concentrations were determined using TCA-Lowery assay. For refolded
TG2, the enzymatic activity, and for refolded domain 2, Native PAGE,
was performed to substantiate their folding.
Aggregation Assay.To set up the aggregation assay, purified TG2
or D2 (0.2 mg/mL) was used in 50 mM glycine buffer pH 212, at 37
and 57 C In order to investigate the effect of metal ions, we used
calcium chloride and sodium chloride (total concentrations were 2 and
10 mM for NaCl and 1, 5, and 10 mM for CaCl2). To investigate the
effect of crowding agent on TG2 aggregation, polyethylene glycols
(Merck, Germany) (PEG) 4000 and 6000 (150 mg/mL) were utilized.
Sodium azide 0.05% was added to the samples and incubated at 37 C.
Turbidity and Thioflavin T Binding Assay. To measure
turbidity, 30 μL aliquots of each sample were diluted up to 500 μL with
50 mM glycine buffer pH 8 and absorbance was measured at 350 nm.
Thioﬂavin T (Sigma, Germany) stock solution was prepared by
dissolving ThT in sodium phosphate (NaH2PO4 50 mM, Na2HPO4
50 mM, pH 8) and ﬁltered through a 0.2 μm ﬁlter. ThT (20 μM) was
added to 30 μL of the sample and ThT ﬂuorescence intensity was
measured at an excitation at 440 nm and emission at 490 nm (excitation
and emission bandwidths were kept within 5 and 10 nm).
Hemolytic Assay for Cytotoxicity. The hemolytic assay was
described elsewhere.33 Briefly, red blood cells were isolated from fresh
blood and washed three times with phosphate buffered saline (PBS)
(pH 7.4). Red blood cells (RBCs) were incubated with samples at 37 C
for 40 min and then centrifuged at 1000 g for 10 min. Absorbance of
supernatant measured at 540 nm is an indicator of the extent of hemolysis.
Circular Dichroism (CD). CD spectra of samples were obtained in
the far-UV region (190260 nm) using a circular dichroism spectro-
meter model 215. The sample concentrations were 0.2 mg/mL and
0.1 cm; quartz cell was utilized.
ANS Fluorescence Assay. Stocks of ANS (Sigma, Germany)
fluorescence assay were prepared by dissolving ANS in absolute ethanol
and filtered using a 0.2 μm filter. Final concentrations of the samples
were 0.05 μM mixed with ANS final concentration 50 μM. ANS was
excited at 390 nm and emission was measured from 420 to 600 nm.
Bandwidths of excitation and emission were 5 and 10 nm, respectively.
Congo Red Birefringence Assay. A staining solution (5 mL)
was made using ethanol/distilled de-ionized (DDI) water in ratio 4:1
and to the staining solution a saturating amount of sodium chloride was
added. The solution was stirred to dissolve sodium chloride and filtered
away the excess sodium chloride. A saturating amount of Congo red
(Merck, Germany) was added to the solution, stirred, and filtered to get
the working solution. The protein samples (10 μL) were added to a
microslide and allowed to dry. An excess amount of staining solution was
added to the dried samples. After removing extra dye, the samples were
visualized under a polarized microscope.
TransmissionElectronicMicroscopy (TEM).Samples (0.2mg/mL)
were diluted 20 times and stained with 1% (w/v) uranyl acetate. The grids
were subsequently washed with DDI, examined, and photographed at an
accelerating voltage of 80 kV.
Atomic Force Microscopy (AFM). Ten microliter samples were
removed from fibrillation reaction, deposited onto very smooth glass,
and air-dried for 5 min. All the images were obtained using a DualScope
DS95 AFMScanner (DME -DanishMicro Engineering A/S, Copenhagen,
Denmark) under ambient conditions. Images were obtained in ac mode.
Each image was taken with 256 data sample points in each sweep line.
The ac probe had a rectangular cantilever with a very sharp silicon
conical tip with a typical resonance frequency of 200 kHz, a force
constant of 40 N/m, and a normal tip radius of less than 10 nm. Several
images were obtained from separate locations to ensure reproducibility.
All the images were analyzed using the accompanied software of the
AFM microscope to calculate height distribution.
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